Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Jefferies Downgrades Bristol-Myers Squibb To Hold
Joe Young  
 
March 31, 2011 7:04am   Comments
Share:

Jefferies & Company has downgraded Bristol-Myers Squibb (NYSE: BMY) from Buy to Hold and maintains its $28.50.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (BMY)

RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Why Is Replimune Stock Trading Lower On Monday?
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Bristol-Myers Squibb Unusual Options Activity For July 31
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
View Comments and Join the Discussion!

Posted-In: bristol-myers squibb Jefferies & CompanyDowngrades Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com